Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc.

NASDAQ:FLGT

Overview | Financials
Company Name Fulgent Genetics, Inc.
Symbol FLGT
Currency USD
Price 19.7
Market Cap 599,738,920
Dividend Yield 0%
52-week-range 14.57 - 25.11
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Ming Hsieh
Website https://www.fulgentgenetics.com

An error occurred while fetching data.

About Fulgent Genetics, Inc.

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for

Related Stocks

Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc.

AUPH

8 USD

BioCryst Pharmaceuticals, Inc. logo

BioCryst Pharmaceuticals, Inc.

BCRX

9.97 USD

SpringWorks Therapeutics, Inc. logo

SpringWorks Therapeutics, Inc.

SWTX

46.26 USD

Apollo Medical Holdings, Inc. logo

Apollo Medical Holdings, Inc.

AMEH

40.82 USD

Ironwood Pharmaceuticals, Inc. logo

Ironwood Pharmaceuticals, Inc.

IRWD

0.709 USD

Myriad Genetics, Inc. logo

Myriad Genetics, Inc.

MYGN

3.89 USD

Financials

Numbers are in millions USD

Numbers are in millions USD